349 related articles for article (PubMed ID: 10816419)
41. Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors.
Soker S; Goldstaub D; Svahn CM; Vlodavsky I; Levi BZ; Neufeld G
Biochem Biophys Res Commun; 1994 Sep; 203(2):1339-47. PubMed ID: 7522446
[TBL] [Abstract][Full Text] [Related]
42. Activation of protein tyrosine phosphorylation after retinal branch vein occlusion in cats.
Hayashi A; Imai K; Kim HC; de Juan E
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):372-80. PubMed ID: 9040470
[TBL] [Abstract][Full Text] [Related]
43. Proteolytic processing regulates receptor specificity and activity of VEGF-C.
Joukov V; Sorsa T; Kumar V; Jeltsch M; Claesson-Welsh L; Cao Y; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1997 Jul; 16(13):3898-911. PubMed ID: 9233800
[TBL] [Abstract][Full Text] [Related]
44. Vascular endothelial growth factor induces the disorganization of actin stress fibers accompanied by protein tyrosine phosphorylation and morphological change in Balb/C3T3 cells.
Enomoto T; Okamoto T; Sato JD
Biochem Biophys Res Commun; 1994 Aug; 202(3):1716-23. PubMed ID: 8060362
[TBL] [Abstract][Full Text] [Related]
45. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.
Soldi R; Mitola S; Strasly M; Defilippi P; Tarone G; Bussolino F
EMBO J; 1999 Feb; 18(4):882-92. PubMed ID: 10022831
[TBL] [Abstract][Full Text] [Related]
46. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
[TBL] [Abstract][Full Text] [Related]
47. Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility.
Takaishi K; Sasaki T; Kato M; Yamochi W; Kuroda S; Nakamura T; Takeichi M; Takai Y
Oncogene; 1994 Jan; 9(1):273-9. PubMed ID: 8302589
[TBL] [Abstract][Full Text] [Related]
48. Rho regulates the hepatocyte growth factor/scatter factor-stimulated cell motility of human oral squamous cell carcinoma cells.
Kitajo H; Shibata T; Nagayasu H; Kawano T; Hamada J; Yamashita T; Arisue M
Oncol Rep; 2003; 10(5):1351-6. PubMed ID: 12883706
[TBL] [Abstract][Full Text] [Related]
49. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
[TBL] [Abstract][Full Text] [Related]
50. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase.
Rousseau S; Houle F; Kotanides H; Witte L; Waltenberger J; Landry J; Huot J
J Biol Chem; 2000 Apr; 275(14):10661-72. PubMed ID: 10744763
[TBL] [Abstract][Full Text] [Related]
51. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells.
Arora N; Masood R; Zheng T; Cai J; Smith DL; Gill PS
Cancer Res; 1999 Jan; 59(1):183-8. PubMed ID: 9892205
[TBL] [Abstract][Full Text] [Related]
52. Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor.
Calnek DS; Grinnell BW
Exp Cell Res; 1998 Jan; 238(1):294-8. PubMed ID: 9457083
[TBL] [Abstract][Full Text] [Related]
53. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.
Guo D; Jia Q; Song HY; Warren RS; Donner DB
J Biol Chem; 1995 Mar; 270(12):6729-33. PubMed ID: 7896817
[TBL] [Abstract][Full Text] [Related]
54. VEGF stimulates tyrosine phosphorylation of beta-catenin and small-pore endothelial barrier dysfunction.
Cohen AW; Carbajal JM; Schaeffer RC
Am J Physiol; 1999 Nov; 277(5):H2038-49. PubMed ID: 10564161
[TBL] [Abstract][Full Text] [Related]
55. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine.
Flatau G; Lemichez E; Gauthier M; Chardin P; Paris S; Fiorentini C; Boquet P
Nature; 1997 Jun; 387(6634):729-33. PubMed ID: 9192901
[TBL] [Abstract][Full Text] [Related]
56. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.
Warner AJ; Lopez-Dee J; Knight EL; Feramisco JR; Prigent SA
Biochem J; 2000 Apr; 347(Pt 2):501-9. PubMed ID: 10749680
[TBL] [Abstract][Full Text] [Related]
57. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively.
Zeng H; Sanyal S; Mukhopadhyay D
J Biol Chem; 2001 Aug; 276(35):32714-9. PubMed ID: 11435426
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo.
Arbiser JL; Larsson H; Claesson-Welsh L; Bai X; LaMontagne K; Weiss SW; Soker S; Flynn E; Brown LF
Am J Pathol; 2000 Apr; 156(4):1469-76. PubMed ID: 10751370
[TBL] [Abstract][Full Text] [Related]
59. A role for cadherin-5 in regulation of vascular endothelial growth factor receptor 2 activity in endothelial cells.
Rahimi N; Kazlauskas A
Mol Biol Cell; 1999 Oct; 10(10):3401-7. PubMed ID: 10512875
[TBL] [Abstract][Full Text] [Related]
60. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1.
Schmidt G; Sehr P; Wilm M; Selzer J; Mann M; Aktories K
Nature; 1997 Jun; 387(6634):725-9. PubMed ID: 9192900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
